THJ-018

Edit links
Source: Wikipedia, the free encyclopedia.
THJ-018
Legal status
Legal status
Identifiers
  • 1-Naphthalenyl(1-pentyl-1H-indazol-3-yl)-methanone
JSmol)
  • O=C(C1=NN(CCCCC)C2=C1C=CC=C2)C3=C4C(C=CC=C4)=CC=C3
  • InChI=1S/C23H22N2O/c1-2-3-8-16-25-21-15-7-6-13-20(21)22(24-25)23(26)19-14-9-11-17-10-4-5-12-18(17)19/h4-7,9-15H,2-3,8,16H2,1H3
  • Key:VAKGBPSFDNTMDJ-UHFFFAOYSA-N

THJ-018 (SGT-17) is a

synthetic cannabinoid that is the indazole analogue of JWH-018 and has been sold online as a designer drug.[1][2]

Pharmacology

THJ-018 acts as a

CB2 cannabinoid receptors.[3]

Legality

THJ-018 is an Anlage II controlled drug in Germany.[4] It is also banned in Sweden.[5]

See also

References

  1. ^ "THJ-018". Cayman Chemical. Retrieved 9 July 2015.
  2. PMID 26430074
    .
  3. PMID 27429655
    .
  4. ^ "Gesetz über den Verkehr mit Betäubungsmitteln (Betäubungsmittelgesetz - BtMG) Anlage II (zu § 1 Abs. 1) (verkehrsfähige, aber nicht verschreibungsfähige Betäubungsmittel)" (in German). Retrieved 9 July 2015.
  5. ^ "Cannabinoider föreslås bli klassade som hälsofarlig vara" (in Swedish). Folkhälsomyndigheten. Retrieved 9 July 2015.
Retrieved from "https://en.wikipedia.org/w/index.php?title=THJ-018&oldid=1186609566"